No Detail Found!

Comparing effect of Double Dose of Hepatitis B Vaccine Verses Conventional Dose in Patients with Chronic Liver Disease

Author(s)
Muhammad Usman Fauji Foundation Hospital, Islamabad, Pakistan
Atif Abbas Fauji Foundation Hospital, Islamabad, Pakistan
Wajid Hussain Fauji Foundation Hospital, Islamabad, Pakistan
Fauzia Khan HITECH Medical College, Taxila, Pakistan
Aamir Afzal Foundation University, Islamabad, Pakistan
Abstract
Objective: To compare the effectiveness of double dose hepatitis B vaccine in patients with chronic liver disease versus conventional-dose. Study design: Randomized control trial Place and Duration: Six months after the approval of synopsis i.e 15th March 2017 to 14th September 2017, Department of General Medicine, FFH, Rawalpindi Methodology: A total of one hundred and sixteen (n=116) diagnosed cases of chronic liver disease of either gender between age 30 to 70 years were enrolled and were divided into two groups one received a double dose (2 ml, 40 µg) and the other received a conventional dose (1 ml, 20 µg). Quantitative anti-HBs was measured at three months in both groups. Mean with standard deviation calculated for quantitative variables like age, anti-HBs level one month after 3rd dose and frequency and percentages in case of categorical variables like gender and effectiveness. Chi-square test was used to determine the significant difference in both groups regarding the effectiveness of vaccination. A pvalue =0.05 was taken significantly. Results: In patients who received double dose seroprotection (anit HBs >10 IU/ml) was achieved in 93.1% (n=54/58) patients, while the percentage was 77.6% (n=45/58) in patients who received a conventional dose (P<0.05). Conclusions: Seroprotection (anit HBs >10 IU/ml) at three months was significantly better in patients who received the double dose of vaccine. Vaccine effectiveness was significantly better in younger age group.
Publication Details
Page(s) 335-339
DOI DOI not available
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 13, Issue: 4, Year: 2017

Request the full text from PASTIC

Keywords
Chronic Liver Disease, HBsAg, Anti HBs.
0

Citations

0

Downloads

66

Views